Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children

PHASE4CompletedINTERVENTIONAL
Enrollment

764

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Haemophilus Influenzae Type B Infection
Interventions
BIOLOGICAL

Haemophilus influenza type b conjugate vaccine

Primary series is 3 doses given to infants beginning at 2 months of age with an interval of 2 months apart (i.e. 2, 4 and 6 months of age). Booster vaccination consists of 1 dose and is given to toddlers 16 to 20 months of age. In this study, subjects will receive vaccination from routine primary care.

Trial Locations (5)

449-812

Moon's Pediatrics Clinic, Gyeonggi-do

407-818

Wooriai Pediatrics clinic, Incheon

130-702

KyungHee University Hospital, Seoul

132-703

Hanil General Hospital, Seoul

134-734

Yonsei Pediatrics Clinic, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY

NCT01404962 - Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children | Biotech Hunter | Biotech Hunter